GHK-Cu 50mg is a synthetic copper-binding tripeptide studied in controlled laboratory environments for its interaction with metalloprotein-associated signaling pathways and intracellular regulatory mechanisms. In experimental biological systems, GHK-Cu 50mg is evaluated for peptide-mediated transcriptional modulation and copper-associated cellular communication dynamics within defined research frameworks.
GHK-Cu (Copper Tripeptide-1) consists of the amino acid sequence Glycyl-L-Histidyl-L-Lysine complexed with a copper ion. Laboratory investigations examine how GHK-Cu 50mg interacts with metalloproteins, transcription factors, and intracellular signaling cascades under controlled in vitro and in vivo experimental conditions.
Research Overview
GHK-Cu 50mg has been examined in preclinical research exploring copper-binding peptide signaling and gene expression regulation models. Scientific interest centers on how copper-associated peptides influence intracellular communication networks and transcriptional regulatory pathways in controlled laboratory systems.
Experimental investigations evaluate molecular markers associated with metalloprotein regulation, extracellular matrix signaling models, kinase activation pathways, and transcription factor modulation when studying GHK-Cu 50mg in defined research environments.
Laboratory frameworks emphasize structural integrity, copper-binding stability, and reproducibility across controlled biological systems.
Mechanism of Study
The mechanism of study for GHK-Cu 50mg involves evaluation of peptide–copper complex interactions with intracellular signaling pathways and metalloprotein-associated regulatory systems within experimental cellular models.
Investigators analyze:
• Copper-binding dynamics
• Metalloprotein interaction markers
• Transcription factor activation pathways
• Intracellular kinase cascades
• Gene expression modulation patterns
Research systems assess how GHK-Cu 50mg influences transcriptional regulation and downstream molecular signaling under validated laboratory protocols. These investigations are conducted strictly for research purposes.
Structural Characteristics
GHK-Cu 50mg is classified as a copper-complexed tripeptide composed of Glycine-Histidine-Lysine bound to a copper ion. Analytical studies focus on molecular weight verification, copper-binding confirmation, peptide sequence integrity, and chromatographic purity validation to ensure research-grade consistency.
Laboratory investigations often include evaluation of copper-chelation stability, structural reproducibility, and intracellular pathway interaction models to better understand structure-activity relationships within peptide research frameworks.
Applications in Research
GHK-Cu 50mg is utilized in experimental systems investigating copper-associated signaling pathways, transcriptional regulation models, and intracellular communication networks. Researchers may evaluate molecular signaling markers, metalloprotein-associated responses, and gene expression patterns influenced by peptide exposure.
Laboratory protocols frequently assess:
• Molecular binding specificity
• Copper-complex stability
• Pathway-specific intracellular responses
• Structural reproducibility across assays
Analytical models emphasize consistency and molecular stability within defined experimental environments.
Product Specifications
• 50mg per vial
• Copper-complexed tripeptide (GHK-Cu)
• Lyophilized powder for enhanced stability
• ≥99% HPLC verified purity
• Third-party tested
• Research use only
• Store at -20°C
GHK-Cu 50mg is supplied in lyophilized form to preserve molecular integrity during storage and transit. Proper laboratory handling procedures are recommended to maintain peptide stability prior to experimental preparation.
Certificate of Analysis
Each batch of GHK-Cu 50mg undergoes independent analytical verification to confirm purity and structural identity. High-Performance Liquid Chromatography (HPLC) testing confirms ≥99% purity prior to release for research distribution.
Additional analytical characterization methods may include mass spectrometry and copper-binding validation procedures to ensure molecular consistency across batches. Certificates of Analysis may be available upon request.
Laboratory Handling & Storage
GHK-Cu 50mg should be stored at -20°C in a temperature-controlled laboratory environment prior to reconstitution. Lyophilized peptide compounds are formulated to maintain stability when handled according to validated laboratory standards.
Upon preparation for experimental procedures, researchers typically follow established laboratory protocols to preserve structural integrity and ensure reliable analytical outcomes.
Frequently Asked Questions
Q: Is GHK-Cu 50mg intended for human consumption?
A: No. This compound is strictly intended for laboratory research use only.
Q: What is GHK-Cu?
A: GHK-Cu 50mg is a copper-complexed tripeptide studied in experimental biological systems.
Q: How is purity verified?
A: Purity is confirmed through validated High-Performance Liquid Chromatography (HPLC) testing procedures.
For research use only. Not for human consumption.
